Puma Biotechnology Sees Q1 Sales $38.000M-$42.000M vs $49.000M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $38.000 million-$42.000 million vs $49.000 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $38.000 million-$42.000 million vs $49.000 million analyst estimate.